InvestorsHub Logo
Followers 69
Posts 6616
Boards Moderated 0
Alias Born 02/10/2010

Re: Steve43 post# 296297

Thursday, 08/18/2022 9:31:41 AM

Thursday, August 18, 2022 9:31:41 AM

Post# of 332950
ENDV Sofpulse used as Predicate Device in 2019 RecoveryRx Post-Op Clearance

<<<<<<< Wouldn’t their product be a predicate device making it easier to apply?>>>>>>>

In BIEL's 2019 RecoveryRx Clearance, K190251, for Post-Op Pain Relief both ActiBand (predesessor to the ActiPatch) and Sofpulse were used as Predicate Devices.

So, the FDA already has experience with a higher power wearable PEMF/PSWT device and accepted it as a Predicate for RecoveryRx.

https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190251.pdf